1,418
Views
4
CrossRef citations to date
0
Altmetric
Research Paper

Long non-coding RNA LINC01296 acts as a migration and invasion promoter in head and neck squamous cell carcinoma and predicts poor prognosis

, , , , &
Pages 5607-5619 | Received 22 Jun 2021, Accepted 04 Aug 2021, Published online: 13 Sep 2021

References

  • Chow L, Longo DL. Head and neck cancer [J]. N Engl J Med. 2020;382(1):60–72.
  • Serafini M, Lopez-Perez L, Fico G, et al. Transcriptomics and Epigenomics in head and neck cancer: available repositories and molecular signatures [J]. Cancers of the head & neck. 2020;5(1):2.
  • Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin. 2018;68(6):394–424.
  • Tumban E, Current A. Update on human papillomavirus-associated head and neck cancers [J]. Viruses. 2019;11(10):922.
  • Lee Y, Li S, Chen Y, et al. Tobacco smoking, alcohol drinking, betel quid chewing, and the risk of head and neck cancer in an East Asian population [J]. Head Neck. 2019;41(1):92–102.
  • Cohen N, Fedewa S, Chen A. Epidemiology and demographics of the head and neck cancer population [J]. Oral Maxillofac Surg Clin North Am. 2018;30(4):381–395.
  • Mehanna H, Paleri V, West C, et al. Head and neck cancer–Part 1: epidemiology, presentation, and prevention [J]. BMJ (Clin Res Ed). 2010;341:c4684.
  • Yan F, Knochelmann H, Morgan P, et al. The evolution of care of cancers of the head and neck region: state of the science in 2020 [J]. Cancers (Basel). 2020;12(6):1543.
  • Forster M, Devlin M. Immune checkpoint inhibition in head and neck cancer [J]. Front Oncol. 2018;8:(310.
  • Sacco A, Cohen E. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma [J]. J Clin Oncol. 2015;33(29):3305–3313.
  • Schmitz S, Grote P, Herrmann B. Mechanisms of long noncoding RNA function in development and disease [J]. Cell Mol Life Sci. 2016;73(13):2491–2509.
  • Guglas K, Bogaczyńska M, Kolenda T, et al. lncRNA in HNSCC: challenges and potential [J]. Contemp Oncol (Pozn). 2017;21(4):259–266.
  • Bhan A, Soleimani M, Mandal S. Long noncoding RNA and Cancer: a new paradigm [J]. Cancer Res. 2017;77(15):3965–3981.
  • Qin Q, Yin Z, Li Y, et al. Long intergenic noncoding RNA 01296 aggravates gastric cancer cells progress through miR-122/MMP-9 [J]. Biomed Pharmacothe. 2018;97:450–457.
  • Wang ZL, Wang C, Liu W, et al. Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer [J]. Biosci Rep. 2019;39(11). DOI:10.1042/BSR20182376.
  • Zhang L, Hu J, Hao M, et al. Long noncoding RNA Linc01296 promotes hepatocellular carcinoma development through regulation of the miR-26a/PTEN axis [J]. Biol Chem. 2020;401(3):407–416. .
  • Wu J, Cheng G, Zhang C, et al. Long noncoding RNA LINC01296 is associated with poor prognosis in prostate cancer and promotes cancer-cell proliferation and metastasis [J]. Onco Targets Ther. 2017;10:1843–1852.
  • Wu D, Han X, Wen X, et al. Long Non-Coding RNA LINC01260 inhibits the proliferation, migration and invasion of spinal cord glioma cells by targeting CARD11 via the NF-κB signaling pathway [J]. Cell Physiol Biochem. 2018;48(4):1563–1578.
  • Tang Z, Li C, Kang B, et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses [J]. Nucleic Acids Res. 2017;45(W1):(W98–W102.
  • Barrett T, Wilhite S, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets–update [J]. Nucleic Acids Res. 2013;41(D1):D991–5.
  • Wu J, Chen Z, Zhang L, et al. Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway [J]. J Cell Biochem. 2020;121(1):867–875.
  • Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets [J]. Nat Commun. 2019;10(1):1523.
  • Xiong Y, Wei Y, Gu Y, et al. DiseaseMeth version 2.0: a major expansion and update of the human disease methylation database [J]. Nucleic Acids Res. 2017;45(D1):D888–D95.
  • Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform [J]. Nat Biotechnol. 2020;38(6):675–678.
  • Peng W, Koirala P, Mo Y. LncRNA-mediated regulation of cell signaling in cancer [J]. Oncogene. 2017;36(41):5661–5667.
  • Kumar MM, Goyal R. LncRNA as a therapeutic target for angiogenesis [J]. Curr Top Med Chem. 2017;17(15):1750–1757.
  • Wang K, Zhang M, Wang C, et al. Long noncoding RNA LINC01296 harbors miR-21a to regulate colon carcinoma proliferation and invasion [J]. Oncol Res. 2019;27(5):541–549.
  • Yu X, Pang L, Yang T, et al. lncRNA LINC01296 regulates the proliferation, metastasis and cell cycle of osteosarcoma through cyclin D1 [J]. Oncol Rep. 2018;40(5):2507–2514.
  • Wan Y, Li M, Huang P. LINC01296 promotes proliferation, migration, and invasion of HCC cells by targeting miR-122-5P and modulating EMT activity [J]. Onco Targets Ther. 2019;12:(2193–203.
  • Wang B, Liang T, Li J. Long noncoding RNA LINC01296 is associated with poor prognosis in ESCC and promotes ESCC cell proliferation, migration and invasion [J]. Eur Rev Med Pharmacol Sci. 2018;22(14):4524–4531.
  • Jiang M, Xiao Y, Liu D, et al. Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer [J]. Gene. (217-24 2018;675: 217–224.
  • Zhang D, Li H, Xie J, et al. Long noncoding RNA LINC01296 promotes tumor growth and progression by sponging miR-5095 in human cholangiocarcinoma [J]. Int J Oncol. 2018;52(6):1777–1786.
  • Singh V, Ram M, Kumar R, et al. Phosphorylation: implications in Cancer [J]. Protein J. 2017;36(1):1–6.
  • Lin C, Yang L. Long noncoding RNA in cancer: wiring signaling circuitry [J]. Trends Cell Biol. 2018;28(4):287–301.
  • Wang J, Lu T, Kung M, et al. The long noncoding RNA LOC441461 (STX17-AS1) modulates colorectal cancer cell growth and motility [J]. Cancers (Basel). 2020;12(11):3171.
  • Liu X, Xiao Z, Han L, et al. LncRNA NBR2 engages a metabolic checkpoint by regulating AMPK under energy stress [J]. Nat Cell Biol. 2016;18(4):431–442.
  • Liu B, Pan S, Xiao Y, et al. LINC01296/miR-26a/GALNT3 axis contributes to colorectal cancer progression by regulating O-glycosylated MUC1 via PI3K/AKT pathway [J]. J Exp Clin Cancer Res. 2018;37(1):316.
  • Arneth B. Tumor microenvironment [J]. Medicina (Kaunas). 2019;56(1).
  • Kondo A, Nonaka A, Shimamura T, et al. Long noncoding RNA JHDM1D-AS1 promotes tumor growth by regulating angiogenesis in response to nutrient starvation [J]. Mol Cell Biol. 2017;37(18). DOI:10.1128/MCB.00125-17.